J&J R&D exec Najat Khan — and data science — are getting an elevated role at the pharma giant
J&J R&D chief Mathai Mammen announced on LinkedIn that Najat Khan, who had been COO in the research arm, has been given the title of chief data science officer — fitting into a trend over the last 2 years as the major players in the industry look for new and better ways to manage the massive and growing volume of data now at their disposal.
Khan, he enthused, is bilingual in two key languages: the science of drug development as well as data sciences. And handled properly, that can guide R&D to more wins with lower costs — a longtime mantra in a world where ROI is generally sorely lacking.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
